|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.900 EUR | +1.04% |
|
-1.02% | +13.37% |
| 05-04 | MEDICLIN Aktiengesellschaft Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 05-04 | MEDICLIN Aktiengesellschaft Revises Earnings Guidance for the Year 2026 | CI |
Company Valuation: MEDICLIN AG
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 186.2 | 171 | 130.2 | 115 | 175.8 | 188.1 | - | - |
| Change | - | -8.16% | -23.89% | -11.68% | 52.89% | 7.03% | - | - |
| Enterprise Value (EV) | 186.2 | 171 | 130.2 | 115 | 175.8 | 188.1 | 188.1 | 188.1 |
| Change | - | -8.16% | -23.89% | -11.68% | 52.89% | 7.03% | 0% | 0% |
| P/E | - | - | - | - | - | - | - | - |
| PBR | 1.02x | 0.82x | 0.66x | 0.52x | 0.71x | 0.66x | 0.59x | 0.52x |
| PEG | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 0.28x | 0.24x | 0.18x | 0.15x | 0.22x | 0.24x | 0.23x | 0.23x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 0.24x | 0.23x | 0.23x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 1.65x | 1.63x | 1.63x |
| EV / EBIT | 0x | 0x | 0x | 0x | 0x | 3.03x | 3.01x | 3x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | 0.04 | 0.04 | 0.04 | 0.04 |
| Rate of return | - | - | - | - | 1.08% | 1.01% | 1.01% | 1.01% |
| EPS 2 | - | - | - | - | - | - | - | - |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 673.1 | 704.7 | 730.1 | 748.8 | 784.5 | 787.5 | 803.2 | 819.3 |
| EBITDA 1 | 85.22 | 90.92 | 98.73 | 103.8 | 115.6 | 114.3 | 115.3 | 115.6 |
| EBIT 1 | 11.56 | 19.52 | 12.72 | 53.49 | 55.36 | 62.11 | 62.47 | 62.72 |
| Net income 1 | 1.461 | 9.441 | -10.78 | 24.84 | 25.49 | 36.66 | 38.2 | 40.12 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 3.920 | 3.600 | 2.740 | 2.420 | 3.700 | 3.960 | 3.960 | 3.960 |
| Nbr of stocks (in thousands) | 47,500 | 47,500 | 47,500 | 47,500 | 47,500 | 47,500 | - | - |
| Announcement Date | 3/30/22 | 3/31/23 | 3/27/24 | 3/28/25 | 3/27/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 32.83x | 3.15x | 14.03x | 1.36% | 18.46B | ||
| 64.8x | 5.11x | 34.6x | 0.27% | 13.1B | ||
| 19.48x | 2.81x | 10.01x | 2.15% | 10.93B | ||
| 16.51x | 1.94x | 9.11x | 0.76% | 10.05B | ||
| 23.05x | 1.86x | 15.51x | 0.16% | 9.45B | ||
| 18.27x | 2.69x | 11x | 4.42% | 9B | ||
| 67.33x | 8.08x | 35.21x | 0.13% | 7.64B | ||
| 32.59x | 0.89x | 7.39x | 1.98% | 6.84B | ||
| 12.61x | 1.1x | 6.68x | 2.07% | 6.81B | ||
| Average | 31.94x | 3.07x | 15.95x | 1.48% | 10.25B | |
| Weighted average by Cap. | 32.93x | 3.17x | 16.51x | 1.41% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- MED Stock
- MED Stock
- Valuation MEDICLIN AG
Select your edition
All financial news and data tailored to specific country editions
















